Bausch & Lomb Corp

    • Earnings Score
    • Moat Score
    • Safety Score
    • Market Cap $7.04B
    • PE -19
    • Debt $4.72B
    • Cash $350.00M
    • EV $11.41B
    • FCF -$58.00M

    Earnings

    loading chart...

    Sales & Net Margins

    loading chart...
    Earnings-$368.00M
    EBIT$124.00M
    ROE-6%
    ROA1%
    FCF-$58.00M
    Equity$6.66B
    Growth Stability-459%
    PE-19.12
    PEG5.13
    PB1.06
    P/FCF-121.34
    P/S1.5
    Price/Cash0.05
    Debt/Equity0.71
    Debt/FCF-81.36
    Net Margins-9%
    Op. Margins3%
    Earnings CAGR-4%
    Sales Growth YoY19%
    Sales Growth QoQ-2%
    Sales CAGR8%
    FCF CAGR-3%
    Equity CAGR-11%
    Earnings Stability-0.87
    Earnings Growth YoY-105%
    Earnings Growth QoQ-103%
    Earnings CAGR 5Y-4%
    Sales CAGR 5Y8%
    FCF CAGR 5Y-3%
    Equity CAGR 5Y-11%
    Earnings CAGR 3Y8%
    Sales CAGR 3Y8%
    FCF CAGR 3Y-7%
    Equity CAGR 3Y-7%
    Market Cap$7.04B
    Revenue$4.68B
    Assets$13.52B
    Total Debt$4.72B
    Cash$350.00M
    Shares Outstanding351.7M
    EV11.41B
    Earnings Score6%
    Moat Score10%
    Safety Score39%
    Final Score18%
    Working Capital1.03B
    Current Ratio1.57
    Shares Growth 3y0%
    Equity Growth QoQ1%
    Equity Growth YoY-3%

    Assets & ROA

    loading chart...

    Stockholders Equity & ROE

    loading chart...
    Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a public company once again in May 2022. The firm reports in three segments-vision care and consumer (60% of revenue), surgical (20%), and ophthalmic pharmaceuticals (20%). The company is geographically diversified, with 48% of revenue in the Americas, 30% from EMEA, and 22% from Asia-Pacific countries.

    SEC Filings

    Direct access to Bausch & Lomb Corp (BLCO) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

    • 2024
      • 10-Q Sep 30
      • 10-Q Jun 30
      • 10-Q Mar 31
    • 2023
      • 10-K Dec 31
      • 10-Q Sep 30
      • 10-Q Jun 30
      • 10-Q Mar 31
    • 2022
      • 10-K Dec 31
      • 10-Q Sep 30
      • 10-Q Jun 30
      • 10-Q Mar 31

    Sector Comparison

    How does Bausch & Lomb Corp compare to its competitors?

    Not enough data to generate a comparison chart between Bausch & Lomb Corp and its competitors. Please check back later.

    Peter Lynch's Chart

    This chart shows the current pricing of Bausch & Lomb Corp compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

    CAGR -4%
    Stability -87%
    loading chart...

    Bausch & Lomb Corp Discounted Cash Flow

    Fully customizable DCF calculator online for Bausch & Lomb Corp.

    = -$463M
    012345678910TV
    fcf-$58M-$56M-$54M-$52M-$51M-$49M-$47M-$46M-$44M-$43M-$41M-$412M
    DCF-$51M-$45M-$39M-$35M-$30M-$27M-$23M-$21M-$18M-$16M-$159M
    Value-$463M

    Competitiveness and MOAT

    High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

    Years12/202012/202112/202212/2023TTM
    Net Margins-1%5%0%-6%-9%
    ROA-3%2%1%1%
    ROE-2%0%-4%-6%

    Safety and Stability

    Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

    Years12/202012/202112/202212/2023TTM
    Debt over FCF-014.78-23.57-81.36
    Debt over Equity-00.350.670.71
    Growth Stability----459%-459%

    Growth

    Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

    Years12/202012/202112/202212/2023CAGR 5Y
    Revenue YoY growth-10%0%10%8%
    Earnings YoY growth--1K%-97%-4K%-4%
    Equity YoY growth--6%-24%-3%-11%
    FCF YoY growth-153%-75%-216%-3%